|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
DK3693025T3
(da)
|
2011-04-22 |
2022-01-10 |
Univ California |
Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
|
|
TWI698240B
(zh)
|
2012-05-15 |
2020-07-11 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
|
SG10201707569YA
(en)
|
2012-12-12 |
2017-10-30 |
Broad Inst Inc |
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
|
|
WO2014124282A1
(en)
|
2013-02-08 |
2014-08-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced aav-mediated gene transfer for retinal therapies
|
|
US10266845B2
(en)
*
|
2013-02-08 |
2019-04-23 |
The Trustees Of The University Of Pennsylvania |
Enhanced AAV-mediated gene transfer for retinal therapies
|
|
BR112015021036A2
(pt)
|
2013-03-15 |
2017-10-10 |
Univ Pennsylvania |
composições e métodos para tratar mps1
|
|
EP2996725A4
(en)
*
|
2013-05-16 |
2016-12-28 |
Applied Genetic Tech Corp |
PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS AND METHODS FOR TREATING COLOR BLINDNESS AND OTHER PROBLEMS
|
|
US11136557B2
(en)
|
2013-05-31 |
2021-10-05 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
WO2014204725A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
JP6738728B2
(ja)
|
2013-06-17 |
2020-08-19 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
肝臓ターゲティングおよび治療のためのＣＲＩＳＰＲ−Ｃａｓ系、ベクターおよび組成物の送達および使用
|
|
ES2777217T3
(es)
|
2013-06-17 |
2020-08-04 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
|
|
EP3011033B1
(en)
|
2013-06-17 |
2020-02-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
WO2014207190A1
(en)
*
|
2013-06-28 |
2014-12-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for expressing a polynucleotide of interest in the retina of a subject
|
|
EP3702461A1
(en)
|
2013-07-08 |
2020-09-02 |
Institut National De La Sante Et De La Recherche Medicale - Inserm |
Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
WO2015089473A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
|
JP6793547B2
(ja)
|
2013-12-12 |
2020-12-02 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
最適化機能ＣＲＩＳＰＲ−Ｃａｓ系による配列操作のための系、方法および組成物
|
|
CN105899658B
(zh)
|
2013-12-12 |
2020-02-18 |
布罗德研究所有限公司 |
针对hbv和病毒性疾病以及障碍的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
KR20160097338A
(ko)
|
2013-12-12 |
2016-08-17 |
더 브로드 인스티튜트, 인코퍼레이티드 |
뉴클레오티드 반복 장애에서의 ｃｒｉｓｐｒ-ｃａｓ 시스템의 조성물 및 방법 및 용도
|
|
CN111206032B
(zh)
*
|
2013-12-12 |
2024-07-19 |
布罗德研究所有限公司 |
用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
GB201403684D0
(en)
*
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015126972A1
(en)
*
|
2014-02-21 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
EP3113787B1
(en)
*
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US9938521B2
(en)
|
2014-03-10 |
2018-04-10 |
Editas Medicine, Inc. |
CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US10307492B2
(en)
*
|
2014-03-11 |
2019-06-04 |
Wayne State University |
Modified MGLUR6 promoter and methods of use
|
|
ES2822551T3
(es)
|
2014-03-17 |
2021-05-04 |
Adverum Biotechnologies Inc |
Composiciones y métodos para la expresión génica mejorada en células de los conos
|
|
EP3981876A1
(en)
|
2014-03-26 |
2022-04-13 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating sickle cell disease
|
|
EP3540061A1
(en)
|
2014-04-02 |
2019-09-18 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating primary open angle glaucoma
|
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
JP2017522895A
(ja)
*
|
2014-07-31 |
2017-08-17 |
ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ オクラホマ |
哺乳類ｒｐｅ６５の高イソメロヒドロラーゼ活性突然変異体
|
|
IL251178B
(en)
*
|
2014-09-16 |
2022-07-01 |
Genzyme Corp |
Adeno-associated viral vector for the treatment of glaucoma myocilin (myoc)
|
|
EP3215191B1
(en)
|
2014-11-05 |
2024-08-14 |
Voyager Therapeutics, Inc. |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
KR20230145206A
(ko)
|
2014-11-14 |
2023-10-17 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
|
CN114717264A
(zh)
|
2014-11-14 |
2022-07-08 |
沃雅戈治疗公司 |
治疗肌萎缩性侧索硬化(als)的组合物和方法
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
EP3985115A1
(en)
|
2014-12-12 |
2022-04-20 |
The Broad Institute, Inc. |
Protected guide rnas (pgrnas)
|
|
WO2016106244A1
(en)
|
2014-12-24 |
2016-06-30 |
The Broad Institute Inc. |
Crispr having or associated with destabilization domains
|
|
EP3256170B1
(en)
*
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US10648000B2
(en)
|
2015-02-16 |
2020-05-12 |
University Of Florida Research Foundation, Incorporated |
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
|
|
CA2977355A1
(en)
*
|
2015-02-20 |
2016-08-25 |
University Of Iowa Research Foundation |
Methods and compositions for treating genetic eye diseases
|
|
FI3265178T3
(fi)
*
|
2015-03-02 |
2026-08-03 |
Adverum Biotechnologies Inc |
Koostumuksia ja menetelmiä polynukleotidien viemiseksi intravitreaalisesti retinaalisiin tappisoluihin
|
|
JP6836999B2
(ja)
*
|
2015-03-24 |
2021-03-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
アデノ随伴ウイルス変異体及びその使用方法
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
EP4019975A1
(en)
|
2015-04-24 |
2022-06-29 |
Editas Medicine, Inc. |
Evaluation of cas9 molecule/guide rna molecule complexes
|
|
US20180140626A1
(en)
*
|
2015-05-14 |
2018-05-24 |
Joslin Diabetes Center, Inc. |
Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degeneration
|
|
EP3929287A3
(en)
|
2015-06-18 |
2022-04-13 |
The Broad Institute, Inc. |
Crispr enzyme mutations reducing off-target effects
|
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
JP6966442B2
(ja)
*
|
2015-12-04 |
2021-11-17 |
ソルボンヌ・ユニヴェルシテSorbonne Universite |
プロモーター及びその使用
|
|
EP3387434A1
(en)
|
2015-12-11 |
2018-10-17 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin c type, and deficiency of mmachc
|
|
AU2016366549B2
(en)
*
|
2015-12-11 |
2022-11-10 |
California Institute Of Technology |
Targeting peptides for directing adeno-associated viruses (AAVs)
|
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
|
MA43968A
(fr)
|
2016-02-03 |
2018-12-12 |
Univ Pennsylvania |
Thérapie génique pour traiter la mucopolysaccharidose de type i
|
|
EP3433364A1
(en)
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
IL262207B2
(en)
|
2016-04-15 |
2026-01-01 |
Univ Pennsylvania |
Preparations for the treatment of wet age-related macular degeneration
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
ES2908467T3
(es)
|
2016-04-29 |
2022-04-29 |
Adverum Biotechnologies Inc |
Evasión de anticuerpos neutralizantes por un virus adenoasociado recombinante
|
|
EP3448411A1
(en)
|
2016-04-29 |
2019-03-06 |
Gensight Biologics SA |
Optogenetic visual restoration using chrimson
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
WO2017192750A1
(en)
*
|
2016-05-04 |
2017-11-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
WO2017197355A2
(en)
|
2016-05-13 |
2017-11-16 |
4D Molecular Therapeutics Inc. |
Adeno-associated virus variant capsids and methods of use thereof
|
|
IL297576B2
(en)
|
2016-05-18 |
2024-02-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
|
US10584337B2
(en)
|
2016-05-18 |
2020-03-10 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
MA44546B1
(fr)
*
|
2016-06-15 |
2021-03-31 |
Univ California |
Virus adéno-associés variants et procédés d'utilisation
|
|
CN117531025A
(zh)
*
|
2016-06-16 |
2024-02-09 |
阿德夫拉姆生物技术股份有限公司 |
使用aav2变体和阿柏西普治疗amd
|
|
PL3472317T3
(pl)
*
|
2016-06-16 |
2022-08-08 |
Adverum Biotechnologies, Inc. |
Kompozycje i sposoby zmniejszania neowaskularyzacji oka
|
|
CN109640949B
(zh)
*
|
2016-07-29 |
2022-11-25 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体和其使用方法
|
|
US11566263B2
(en)
|
2016-08-02 |
2023-01-31 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290 associated disease
|
|
WO2018044912A1
(en)
|
2016-08-29 |
2018-03-08 |
Wayne State University |
Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
|
|
EP3831281B1
(en)
|
2016-08-30 |
2026-02-25 |
The Regents of The University of California |
Devices and systems for biomedical targeting and delivery
|
|
AU2017345470B2
(en)
|
2016-10-19 |
2023-08-03 |
Adverum Biotechnologies, Inc. |
Modified AAV capsids and uses thereof
|
|
EP3535282A4
(en)
*
|
2016-11-06 |
2020-04-08 |
Nanoscope Technologies LLC |
OPTOGENETIC MODULATION BY OPSINS WITH MULTIPLE CHARACTERISTICS FOR RESTORATION OF VISION AND OTHER ASSOCIATED APPLICATIONS
|
|
US11236360B2
(en)
|
2016-12-09 |
2022-02-01 |
Regents Of The University Of Minnesota |
Adeno-associated viruses engineered for selectable tropism
|
|
JP2020508289A
(ja)
|
2017-01-31 |
2020-03-19 |
レジェンクスバイオ インコーポレーテッド |
完全ヒトグリコシル化ヒトα−Ｌ−イズロニダーゼ（ＩＤＵＡ）を用いたムコ多糖症Ｉ型の治療
|
|
JP2020510424A
(ja)
*
|
2017-02-28 |
2020-04-09 |
アドヴェラム バイオテクノロジーズ， インコーポレイテッド |
改変ａａｖカプシドおよびその使用
|
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
KR102616820B1
(ko)
|
2017-03-17 |
2023-12-21 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
향상된 유전자 발현을 위한 조성물 및 방법
|
|
EP4219806A3
(en)
*
|
2017-04-11 |
2023-09-27 |
Ruprecht-Karls-Universität Heidelberg |
Adeno-associated virus library
|
|
KR20240093919A
(ko)
|
2017-04-14 |
2024-06-24 |
리젠엑스바이오 인크. |
인간 뉴런 또는 신경교 세포에 의해 생성된 재조합 인간 이두로네이트-2 설파타제(ids)를 이용한 뮤코다당증 ii형의 치료
|
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
EP3622070A2
(en)
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
KR20250023600A
(ko)
*
|
2017-06-30 |
2025-02-18 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법
|
|
CA3068328A1
(en)
|
2017-07-06 |
2019-01-10 |
The Trustees Of The University Of Pennsylvania |
Aav9-mediated gene therapy for treating mucopolysaccharidosis type i
|
|
CA3070087A1
(en)
|
2017-07-17 |
2019-01-24 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
MX2020001997A
(es)
|
2017-08-28 |
2020-07-20 |
Univ California |
Variantes de capside de virus adenoasociado y metodos de uso de estas.
|
|
DK3684423T5
(da)
|
2017-09-20 |
2024-08-26 |
4D Molecular Therapeutics Inc |
Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
|
|
MX2020003042A
(es)
|
2017-09-29 |
2020-11-18 |
Voyager Therapeutics Inc |
Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
|
|
AU2018350700B2
(en)
*
|
2017-10-16 |
2025-04-24 |
VeonGen Therapeutics GmbH |
AAV vectors
|
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
TW202413649A
(zh)
|
2017-10-16 |
2024-04-01 |
美商航海家醫療公司 |
肌萎縮性脊髓側索硬化症(als)之治療
|
|
MX2020003945A
(es)
|
2017-10-18 |
2020-11-09 |
Regenxbio Inc |
Tratamiento de enfermedades oculares y cancer de colon metastasico con vegf-trap humano modificado post-traduccionalmente .
|
|
KR20200067195A
(ko)
|
2017-10-18 |
2020-06-11 |
리젠엑스바이오 인크. |
완전-인간 번역후 변형된 항체 치료제
|
|
KR102763312B1
(ko)
*
|
2017-10-20 |
2025-02-07 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
치료적으로 유효한 양의 재조합 aav9- 유도 벡터의 망막하 전달을 포함하는 대상체의 원추 광수용체 내 관심의 폴리뉴클레오티드를 발현하는 방법
|
|
WO2019084015A1
(en)
*
|
2017-10-23 |
2019-05-02 |
Daniel Schmidt |
PROGRAMMABLE SET OF VIRUS COMPOSITES FOR ADMINISTRATION OF GENES TARGETING A RECEPTOR
|
|
US11766489B2
(en)
|
2017-11-27 |
2023-09-26 |
4D Molecular Therapeutics, Inc. |
Adeno-associated virus variant capsids and use for inhibiting angiogenesis
|
|
WO2019152841A1
(en)
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for pah gene transfer and methods of use thereof
|
|
AU2019215152A1
(en)
|
2018-02-01 |
2020-08-20 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring PAH gene function and methods of use thereof
|
|
EP3749754A4
(en)
*
|
2018-02-08 |
2021-10-20 |
Applied Stemcell, Inc. |
TARGET GENE VARIANT SCREENING METHODS
|
|
US11306329B2
(en)
|
2018-02-19 |
2022-04-19 |
City Of Hope |
Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
|
|
US12558434B2
(en)
|
2018-02-20 |
2026-02-24 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
IL277234B2
(en)
|
2018-03-14 |
2026-03-01 |
Editas Medicine Inc |
Systems and methods for treating hemoglobin diseases
|
|
MX2020010465A
(es)
*
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
CA3098566A1
(en)
|
2018-04-29 |
2019-11-07 |
Zhuchun WU |
Systems and methods of spectrophotometry for the determination of genome content, capsid content and full/empty ratios of adeno-associated virus particles
|
|
CA3098565A1
(en)
|
2018-04-29 |
2019-11-07 |
Claire G. ZHANG |
Scalable clarification process for recombinant aav production
|
|
IL278598B2
(en)
*
|
2018-05-11 |
2025-11-01 |
Massachusetts Eye & Ear Infirmary |
Altering tissue tropism of adeno-associated viruses
|
|
US11821009B2
(en)
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
IL319002A
(en)
|
2018-06-14 |
2025-04-01 |
Regenxbio Inc |
Anion exchange chromatography for recombinant AAV production
|
|
EP3808840A4
(en)
*
|
2018-06-14 |
2022-03-23 |
Avixgen Inc. |
Pharmaceutical composition comprising fusion protein of cell-penetrating peptide and rpe65 for treatment of leber's congenital amaurosis
|
|
JP2021530218A
(ja)
|
2018-07-11 |
2021-11-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. |
血液脳関門を超える薬剤の送達のための方法および組成物
|
|
WO2020033842A1
(en)
|
2018-08-10 |
2020-02-13 |
Regenxbio Inc. |
Scalable method for recombinant aav production
|
|
US11149256B2
(en)
|
2018-09-26 |
2021-10-19 |
California Institute Of Technology |
Adeno-associated virus compositions for targeted gene therapy
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
AU2019354296A1
(en)
|
2018-10-01 |
2021-04-29 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating propionic acidemia
|
|
CN113166208B
(zh)
|
2018-10-02 |
2024-11-22 |
沃雅戈治疗公司 |
重新定向aav衣壳的嗜性
|
|
JP2022514112A
(ja)
|
2018-10-15 |
2022-02-09 |
リジェネクスバイオ インコーポレイテッド |
複製欠損型ウイルスベクター及びウイルスの感染性を測定するための方法
|
|
BR112021009913A2
(pt)
*
|
2018-12-05 |
2021-08-17 |
Abeona Therapeutics, Inc. |
vetor viral adeno-associado recombinante para inserção gênica
|
|
CA3122272A1
(en)
|
2018-12-12 |
2020-06-18 |
Tesseract Health, Inc. |
Optical apparatus and associated devices for biometric identification and health status determination
|
|
CN113825521A
(zh)
|
2018-12-21 |
2021-12-21 |
美利坚合众国由健康及人类服务部部长代表 |
腺相关病毒及其用于内耳疗法的用途
|
|
CN110437317B
(zh)
*
|
2019-01-30 |
2023-05-02 |
上海科技大学 |
具有变异衣壳蛋白的腺相关病毒及其用途
|
|
KR20210126096A
(ko)
|
2019-02-15 |
2021-10-19 |
상가모 테라퓨틱스, 인코포레이티드 |
재조합 aav를 제조하기 위한 조성물 및 방법
|
|
EP3931335A2
(en)
|
2019-02-25 |
2022-01-05 |
Novartis AG |
Compositions and methods to treat bietti crystalline dystrophy
|
|
US20220154210A1
(en)
|
2019-02-25 |
2022-05-19 |
Novartis Ag |
Compositions and methods to treat bietti crystalline dystrophy
|
|
CN111621502B
(zh)
*
|
2019-02-28 |
2023-05-02 |
武汉纽福斯生物科技有限公司 |
视网膜劈裂蛋白的编码序列、其表达载体构建及其应用
|
|
EP3930694A1
(en)
|
2019-02-28 |
2022-01-05 |
Regeneron Pharmaceuticals, Inc. |
Adeno-associated virus vectors for the delivery of therapeutics
|
|
WO2020180951A1
(en)
|
2019-03-04 |
2020-09-10 |
Adverum Biotechnologies, Inc. |
Sequential intravitreal administration of aav gene therapy to contralateral eyes
|
|
EP3715358A1
(en)
*
|
2019-03-28 |
2020-09-30 |
Universität zu Köln |
Mutated adeno-associated virus capsid proteins, aav particle comprising the same and liver directed aav vector gene therapy
|
|
CN114450411A
(zh)
|
2019-04-01 |
2022-05-06 |
特纳亚治疗股份有限公司 |
具有工程化衣壳的腺相关病毒
|
|
EP4667578A3
(en)
|
2019-04-03 |
2026-04-01 |
REGENXBIO Inc. |
Gene therapy for eye pathologies
|
|
TW202102526A
(zh)
*
|
2019-04-04 |
2021-01-16 |
美商銳進科斯生物股份有限公司 |
重組腺相關病毒及其用途
|
|
ES2965341T3
(es)
|
2019-04-11 |
2024-04-12 |
Regenxbio Inc |
Métodos de cromatografía de exclusión por tamaño para la caracterización de composiciones de virus adenoasociados recombinantes
|
|
JP7630443B2
(ja)
|
2019-04-19 |
2025-02-17 |
レジェンクスバイオ インコーポレーテッド |
アデノ随伴ウイルスベクター製剤及び方法
|
|
US20220195462A1
(en)
|
2019-04-24 |
2022-06-23 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
CA3132447A1
(en)
|
2019-04-24 |
2020-10-29 |
Takara Bio Inc. |
Aav mutant having brain-targeting property
|
|
TWI862583B
(zh)
*
|
2019-04-26 |
2024-11-21 |
美商愛德維仁生物科技公司 |
用於玻璃體內遞送之變異體aav蛋白殼
|
|
JP2022530845A
(ja)
*
|
2019-04-27 |
2022-07-04 |
オクジェン アイエヌシー． |
眼疾患に対するａｄｅｎｏ随伴ウイルス連ウイルスベクター媒介遺伝子治療
|
|
US11737665B2
(en)
|
2019-06-21 |
2023-08-29 |
Tesseract Health, Inc. |
Multi-modal eye imaging with shared optical path
|
|
CN114269352A
(zh)
*
|
2019-06-27 |
2022-04-01 |
佛罗里达大学研究基金会 |
用透明质酸增强aav介导的眼组织转导
|
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
|
EP3997214B1
(en)
*
|
2019-07-11 |
2023-08-02 |
Centre National de la Recherche Scientifique |
Chemically-modified adeno-associated virus
|
|
US10653731B1
(en)
|
2019-07-15 |
2020-05-19 |
Vigene Biosciences Inc. |
Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
|
|
US10557149B1
(en)
|
2019-07-15 |
2020-02-11 |
Vigene Biosciences, Inc. |
Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
|
|
US10801042B1
(en)
|
2019-07-15 |
2020-10-13 |
Vigene Biosciences, Inc. |
Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus
|
|
EP4004214A1
(en)
|
2019-07-26 |
2022-06-01 |
RegenxBio Inc. |
Engineered nucleic acid regulatory element and methods of uses thereof
|
|
RU2751592C2
(ru)
|
2019-08-22 |
2021-07-15 |
Общество С Ограниченной Ответственностью "Анабион" |
Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
|
|
CA3149401A1
(en)
|
2019-08-26 |
2021-03-04 |
Stephen Joseph Pakola |
Treatment of diabetic retinopathy with fully-human post-translationally modified anti-vegf fab
|
|
CA3153972A1
(en)
|
2019-09-09 |
2021-03-18 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
|
|
FI4027983T3
(fi)
|
2019-09-11 |
2026-02-03 |
Adverum Biotechnologies Inc |
Silmän neovaskulaaristen sairauksien hoito afliberseptiä koodaavilla aav2-varianteilla
|
|
CN114375195A
(zh)
|
2019-09-11 |
2022-04-19 |
阿德夫拉姆生物技术股份有限公司 |
使用编码阿柏西普的aav2变体治疗眼新血管疾病的方法
|
|
US20220325296A1
(en)
*
|
2019-09-12 |
2022-10-13 |
The Broad Institute, Inc. |
Engineered adeno-associated virus capsids
|
|
GB201913974D0
(en)
|
2019-09-27 |
2019-11-13 |
King S College London |
Vector
|
|
WO2021067598A1
(en)
|
2019-10-04 |
2021-04-08 |
Ultragenyx Pharmaceutical Inc. |
Methods for improved therapeutic use of recombinant aav
|
|
WO2021071835A1
(en)
|
2019-10-07 |
2021-04-15 |
Regenxbio Inc. |
Adeno-associated virus vector pharmaceutical composition and methods
|
|
WO2021073568A1
(en)
*
|
2019-10-16 |
2021-04-22 |
Wuxi Apptec (Shanghai) Co., Ltd. |
A novel aav variant
|
|
JP2022551986A
(ja)
|
2019-10-16 |
2022-12-14 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
修飾筋肉標的化組成物
|
|
CN114729009A
(zh)
*
|
2019-10-31 |
2022-07-08 |
伯尔尼大学 |
用于眼部基因递送的aav载体变体
|
|
US12521451B2
(en)
*
|
2019-11-08 |
2026-01-13 |
Regeneron Pharmaceuticals, Inc. |
CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
|
|
WO2021099394A1
(en)
|
2019-11-19 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antisense oligonucleotides and their use for the treatment of cancer
|
|
CN115335529B
(zh)
*
|
2019-11-26 |
2026-07-03 |
马萨诸塞大学 |
用于递送kh902(康柏西普)的重组腺相关病毒及其用途
|
|
AU2020392243A1
(en)
|
2019-11-28 |
2022-06-16 |
Regenxbio Inc. |
Microdystrophin gene therapy constructs and uses thereof
|
|
CA3167290A1
(en)
*
|
2020-01-10 |
2021-07-15 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for delivery of immunotherapy agents across the blood-brain barrier to treat brain cancer
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
KR20220131522A
(ko)
|
2020-01-22 |
2022-09-28 |
리젠엑스바이오 인크. |
완전-인간 글리코실화된 인간 알파-l-이두로니다아제 (idua)를 사용한 점액다당류증 i의 치료
|
|
BR112022015036A2
(pt)
|
2020-01-29 |
2022-10-11 |
Regenxbio Inc |
Vírus adenoassociado recombinante (raav), composição farmacêutica, polinucleotídeo, plasmídeo de raav, célula ex vivo, método de produção de um raav, método para tratar um sujeito humano diagnosticado com mucopolissacaridose tipo iva (mps iva)
|
|
US20230088992A1
(en)
|
2020-01-29 |
2023-03-23 |
Regenxbio Inc. |
Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells
|
|
AU2021218703A1
(en)
|
2020-02-14 |
2022-07-28 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating CDKL5 deficiency disorder
|
|
US20230235353A1
(en)
|
2020-03-19 |
2023-07-27 |
Ultragenyx Pharmaceutical Inc. |
Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant aav
|
|
US12686874B2
(en)
|
2020-03-31 |
2026-07-21 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating propionic acidemia
|
|
WO2021204407A1
(en)
|
2020-04-10 |
2021-10-14 |
Sorbonne Université |
G-protein-gated-k+ channel-mediated enhancements in light sensitivity in rod-cone dystrophy (rcd)
|
|
AU2021259422A1
(en)
|
2020-04-20 |
2022-12-08 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
EP4138929A1
(en)
|
2020-04-24 |
2023-03-01 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for preventing induction of immune responses to the transduced cells expressing a transgene product after ocular gene therapy
|
|
CA3175905A1
(en)
|
2020-04-27 |
2021-11-04 |
David H. Kirn |
Codon optimized gla genes and uses thereof
|
|
US12630842B2
(en)
|
2020-05-13 |
2026-05-19 |
Voyager Therapeutics, Inc. |
Redirection of tropism of AAV capsids
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
WO2021243085A2
(en)
|
2020-05-29 |
2021-12-02 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsids and methods of use thereof
|
|
KR20230050336A
(ko)
|
2020-07-10 |
2023-04-14 |
인스티튜트 내셔널 드 라 싼테 에 드 라 리셰르셰 메디칼르 (인 썸) |
뇌전증을 치료하기 위한 방법과 조성물
|
|
US12668814B2
(en)
|
2020-07-22 |
2026-06-30 |
The Broad Institute, Inc. |
Engineered muscle targeting compositions
|
|
EP4199972A4
(en)
*
|
2020-08-21 |
2025-01-15 |
Capsida, Inc. |
ADENO-ASSOCIATED VIRUS COMPOSITIONS WITH PREFERRED EXPRESSION LEVELS
|
|
CN112226461B
(zh)
*
|
2020-08-21 |
2022-04-22 |
华侨大学 |
Cd4阳性细胞特异性基因传递载体及其应用
|
|
US12129287B2
(en)
|
2020-09-14 |
2024-10-29 |
President And Fellows Of Harvard College |
Recombinant adeno associated virus encoding clarin-1 and uses thereof
|
|
US20250326861A1
(en)
|
2020-09-15 |
2025-10-23 |
Regenxbio Inc. |
Vectorized lanadelumab and administration thereof
|
|
EP4214242A1
(en)
|
2020-09-15 |
2023-07-26 |
RegenxBio Inc. |
Vectorized antibodies for anti-viral therapy
|
|
CN112194706B
(zh)
*
|
2020-09-30 |
2022-03-08 |
广州派真生物技术有限公司 |
腺相关病毒突变体及其应用
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
EP4225777A2
(en)
|
2020-10-07 |
2023-08-16 |
RegenxBio Inc. |
Adeno-associated viruses for ocular delivery of gene therapy
|
|
TW202228648A
(zh)
|
2020-10-07 |
2022-08-01 |
美商銳進科斯生物股份有限公司 |
諸如高黏度調配物之用於脈絡膜上投與之調配物
|
|
TW202228646A
(zh)
|
2020-10-07 |
2022-08-01 |
美商銳進科斯生物股份有限公司 |
諸如凝膠調配物之用於脈絡膜上投與之調配物
|
|
EP4225381A1
(en)
|
2020-10-07 |
2023-08-16 |
RegenxBio Inc. |
Formulations for suprachoroidal administration such as formulations with aggregate formation
|
|
JP7415042B2
(ja)
|
2020-10-09 |
2024-01-16 |
テナヤ セラピューティクス， インコーポレイテッド |
プラコフィリン２遺伝子治療の方法および組成物
|
|
WO2022094157A1
(en)
|
2020-10-28 |
2022-05-05 |
Regenxbio Inc. |
Vectorized anti-cgrp and anti-cgrpr antibodies and administration thereof
|
|
AU2021371307A1
(en)
|
2020-10-28 |
2023-06-01 |
Regenxbio, Inc. |
VECTORIZED ANTI-TNF-α ANTIBODIES FOR OCULAR INDICATIONS
|
|
KR20230098176A
(ko)
|
2020-10-29 |
2023-07-03 |
리젠엑스바이오 인크. |
안구 적응증을 위한 벡터화된 tnf-알파 길항제
|
|
US20230390418A1
(en)
|
2020-10-29 |
2023-12-07 |
Regenxbio Inc. |
Vectorized factor xii antibodies and administration thereof
|
|
AU2021378270A1
(en)
*
|
2020-11-10 |
2023-06-15 |
Avirmax Biopharma Inc. |
Engineered viral capsids and methods of use
|
|
US20240002839A1
(en)
|
2020-12-02 |
2024-01-04 |
Decibel Therapeutics, Inc. |
Crispr sam biosensor cell lines and methods of use thereof
|
|
EP4263841A1
(en)
|
2020-12-16 |
2023-10-25 |
REGENXBIO Inc. |
Method of producing a recombinant adeno-associated virus particle
|
|
US20240067678A1
(en)
*
|
2020-12-16 |
2024-02-29 |
Children's Medical Research Institute |
Adeno-associated virus capsids and vectors
|
|
US20240309076A1
(en)
|
2020-12-29 |
2024-09-19 |
Regenxbio Inc. |
Tau-specific antibody gene therapy compositions, methods and uses thereof
|
|
AU2022210592A1
(en)
|
2021-01-21 |
2023-07-13 |
Regenxbio Inc. |
Improved production of recombinant polypeptides and viruses
|
|
AU2022221284A1
(en)
|
2021-02-10 |
2023-08-17 |
Regenxbio Inc. |
Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids)
|
|
CN113121651B
(zh)
*
|
2021-04-19 |
2023-11-17 |
信念医药科技(上海)有限公司 |
低中和抗体腺相关病毒衣壳蛋白
|
|
CN113121652B
(zh)
*
|
2021-04-19 |
2022-10-11 |
上海信致医药科技有限公司 |
视网膜和肌肉高亲和性腺相关病毒衣壳蛋白及相关应用
|
|
ES3034370T3
(en)
|
2021-04-20 |
2025-08-18 |
Inst Nat Sante Rech Med |
Compositions and methods for treating retinal degenerative disorders
|
|
IL307902A
(en)
|
2021-04-26 |
2023-12-01 |
Regenxbio Inc |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
CN117222400A
(zh)
|
2021-04-27 |
2023-12-12 |
阿德夫拉姆生物技术股份有限公司 |
使用编码阿柏西普的aav2变体治疗眼部疾病的方法
|
|
EP4334454A2
(en)
|
2021-05-04 |
2024-03-13 |
RegenxBio Inc. |
Novel aav vectors and methods and uses thereof
|
|
US20240358857A1
(en)
|
2021-05-11 |
2024-10-31 |
Regenxbio Inc. |
Treatment of duchenne muscular dystrophy and combinations thereof
|
|
WO2022248634A1
(en)
|
2021-05-26 |
2022-12-01 |
Sparingvision |
G-protein-gated-k+ channel-mediated enhancements in light sensitivity in rod-cone dystrophy (rcd)
|
|
EP4349852A4
(en)
*
|
2021-05-28 |
2025-09-03 |
Shanghai Regenelead Therapies Co Ltd |
RECOMBINANT ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID, AND ITS APPLICATION
|
|
AU2022283898A1
(en)
*
|
2021-06-03 |
2024-01-04 |
Dyno Therapeutics, Inc. |
Capsid variants and methods of using the same
|
|
EP4366757A1
(en)
|
2021-07-07 |
2024-05-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Synergistic combination of rdcfv2 and rdcvf2l for the treatment of tauopathies
|
|
CR20240004A
(es)
|
2021-07-08 |
2024-06-11 |
Biocad Joint Stock Co |
Composición farmacéutica de virus no encapsulado
|
|
TW202317768A
(zh)
|
2021-07-08 |
2023-05-01 |
美商特納亞治療股份有限公司 |
用於基因療法的優化表現卡匣
|
|
AU2022313258A1
(en)
|
2021-07-19 |
2024-02-08 |
New York University |
Auf1 combination therapies for treatment of muscle degenerative disease
|
|
JP2024531138A
(ja)
|
2021-08-11 |
2024-08-29 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
筋ジストロフィーを処置するための組成物および方法
|
|
AR126840A1
(es)
|
2021-08-20 |
2023-11-22 |
Llc «Anabion» |
Proteína de la cápside vp1 modificada aislada del virus adeno-asociado de serotipo 5 (aav5), cápside y vector basado en esta
|
|
CA3229580A1
(en)
|
2021-08-20 |
2023-02-23 |
Anna Nikolaevna STRELKOVA |
Method for producing modified adeno-associated virus capsid
|
|
AR126839A1
(es)
|
2021-08-20 |
2023-11-22 |
Llc «Anabion» |
Proteína de la cápside vp1 modificada aislada del virus adeno-asociado de serotipo 9 (aav9), cápside y vector basado en esta
|
|
WO2023060113A1
(en)
|
2021-10-05 |
2023-04-13 |
Regenxbio Inc. |
Compositions and methods for recombinant aav production
|
|
CN118202060A
(zh)
|
2021-10-05 |
2024-06-14 |
再生生物股份有限公司 |
用于重组aav生产的组合物和方法
|
|
EP4413019A2
(en)
|
2021-10-07 |
2024-08-14 |
RegenxBio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
EP4413018A1
(en)
|
2021-10-07 |
2024-08-14 |
RegenxBio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
KR20240095539A
(ko)
|
2021-10-08 |
2024-06-25 |
디노 테라퓨틱스, 인코포레이티드 |
캡시드 변이체 및 이의 사용 방법
|
|
US20230338581A1
(en)
|
2021-10-11 |
2023-10-26 |
Sparingvision |
G-protein-gated-k+ channel-mediated enhancements in light sensitivity in rod-cone dystrophy (rcd)
|
|
EP4423285A1
(en)
|
2021-10-28 |
2024-09-04 |
RegenxBio Inc. |
Engineered nucleic acid regulatory elements and methods and uses thereof
|
|
EP4426716A1
(en)
|
2021-11-02 |
2024-09-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
CN120187407A
(zh)
*
|
2021-12-15 |
2025-06-20 |
健达九州(北京)生物科技有限公司 |
重组aav载体及其用途
|
|
JP2025506383A
(ja)
|
2022-02-02 |
2025-03-11 |
アドヴェラム バイオテクノロジーズ， インコーポレイテッド |
アフリベルセプトをコードするａａｖ２バリアントを使用して眼内血管新生疾患を処置する方法
|
|
KR20240161978A
(ko)
|
2022-02-16 |
2024-11-13 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
재조합 아데노 관련 바이러스에 의한 신혈관성 amd의 cst 변동을 감소시키는 방법
|
|
KR20240152351A
(ko)
|
2022-02-17 |
2024-10-21 |
스카이라인 테라퓨틱스 리미티드 |
변형된 aav 캡시드 폴리펩티드를 갖는 재조합 아데노-연관 바이러스
|
|
CA3245327A1
(en)
|
2022-03-07 |
2023-09-14 |
Ultragenyx Pharmaceutical Inc. |
MODIFIED BATCH-BASED AAV PRODUCTION SYSTEMS AND PROCESSES
|
|
EP4493226A1
(en)
|
2022-03-13 |
2025-01-22 |
RegenxBio Inc. |
Modified muscle-specific promoters
|
|
US20250213727A1
(en)
|
2022-03-25 |
2025-07-03 |
Regenxbio Inc. |
Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy
|
|
CA3255242A1
(en)
*
|
2022-03-30 |
2023-10-05 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Adeno-associated viral vectors for the delivery of nucleic acids across retinal regions
|
|
TW202346600A
(zh)
*
|
2022-03-30 |
2023-12-01 |
高等教育聯邦系統 匹茲堡大學 |
用於將核酸遞送至視網膜神經節細胞和/或視網膜色素上皮細胞的腺相關病毒載體
|
|
US20250327092A1
(en)
*
|
2022-03-30 |
2025-10-23 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Adeno-associated virus vectors for nucleic acid delivery to retinal cells
|
|
EP4499669A4
(en)
*
|
2022-03-30 |
2026-06-24 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Adenoid-associated viral vectors
|
|
AU2023250660A1
(en)
|
2022-04-06 |
2024-10-24 |
Regenxbio Inc. |
Pharmaceutical composition comprising a recombinant adenoassociated virus vector with an expression cassette encoding a transgene for suprachoroidal administration
|
|
TW202404651A
(zh)
|
2022-04-06 |
2024-02-01 |
美商銳進科斯生物股份有限公司 |
用於脈絡膜上投與之調配物諸如形成聚集體之調配物
|
|
TW202345913A
(zh)
|
2022-04-06 |
2023-12-01 |
美商銳進科斯生物股份有限公司 |
用於脈絡膜上投與之調配物諸如凝膠調配物
|
|
WO2023201207A1
(en)
|
2022-04-11 |
2023-10-19 |
Tenaya Therapeutics, Inc. |
Adeno-associated virus with engineered capsid
|
|
CN120590489A
(zh)
*
|
2022-04-12 |
2025-09-05 |
合肥星眸生物科技有限公司 |
一种融合型腺相关病毒及其应用
|
|
US20250249127A1
(en)
|
2022-04-14 |
2025-08-07 |
Regenxbio Inc. |
Gene therapy for treating an ocular disease
|
|
WO2023201277A1
(en)
|
2022-04-14 |
2023-10-19 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns tropic delivery
|
|
CN116970648A
(zh)
*
|
2022-04-24 |
2023-10-31 |
上海朗昇生物科技有限公司 |
新型aav衣壳改造株及其用途
|
|
TW202417633A
(zh)
|
2022-05-03 |
2024-05-01 |
美商銳進科斯生物股份有限公司 |
用於眼適應症之載體化抗TNF-α抑制劑
|
|
TW202400803A
(zh)
|
2022-05-03 |
2024-01-01 |
美商銳進科斯生物股份有限公司 |
載體化抗補體抗體與補體劑及其投與
|
|
CA3252767A1
(en)
|
2022-06-07 |
2023-12-14 |
Adverum Biotechnologies, Inc. |
VARIANTS OF MELANOPSINE FOR VISION RESTORATION
|
|
WO2023239627A2
(en)
|
2022-06-08 |
2023-12-14 |
Regenxbio Inc. |
Methods for recombinant aav production
|
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
|
JP2025528188A
(ja)
|
2022-08-11 |
2025-08-26 |
インスティテュート オブ モレキュラー アンド クリニカル オフサルモロジー バーゼル （アイオービー） |
ヒト錐体光受容体オプトジェネティクス構築物
|
|
WO2024044725A2
(en)
|
2022-08-24 |
2024-02-29 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
|
EP4593955A1
(en)
|
2022-09-30 |
2025-08-06 |
RegenxBio Inc. |
Treatment of ocular diseases with recombinant viral vectors encoding anti-vegf fab
|
|
JP2025534666A
(ja)
|
2022-10-11 |
2025-10-17 |
リジェネックスバイオ インコーポレイテッド |
操作された核酸調節エレメントならびにその使用方法
|
|
KR20250115381A
(ko)
|
2022-10-20 |
2025-07-30 |
스페어링비젼 |
망막 변성 질환 치료를 위한 조성물 및 방법
|
|
EP4357359A1
(en)
|
2022-10-20 |
2024-04-24 |
Sparingvision |
G-protein-gated-k+ channel-mediated enhancements in light sensitivity in rod-cone dystrophy (rcd)
|
|
JP2025538387A
(ja)
|
2022-11-16 |
2025-11-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
プロテアーゼ切断可能なリンカーを有する膜結合ｉｌ－１２を含むキメラタンパク質
|
|
WO2024146935A1
(en)
|
2023-01-06 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Intravenous administration of antisense oligonucleotides for the treatment of pain
|
|
CN118359687A
(zh)
*
|
2023-01-18 |
2024-07-19 |
上海朗昇生物科技有限公司 |
一种新衣壳蛋白变体以及其用途
|
|
KR20250142340A
(ko)
|
2023-02-02 |
2025-09-30 |
퀘세라 리미티드 |
재조합 아데노-부속 바이러스 벡터
|
|
JP2026509271A
(ja)
|
2023-03-10 |
2026-03-17 |
ダイノ セラピューティクス，インコーポレーテッド |
カプシドポリペプチドおよびその使用方法
|
|
WO2024192281A2
(en)
|
2023-03-15 |
2024-09-19 |
Regenxbio Inc. |
Exon skipping gene therapy constructs, vectors and uses thereof
|
|
WO2024211831A1
(en)
|
2023-04-05 |
2024-10-10 |
Adverum Biotechnologies, Inc. |
Immune landscape signatures for ocular inflammation
|
|
JP2026513932A
(ja)
|
2023-04-07 |
2026-05-01 |
リジェネクスバイオ インコーポレイテッド |
組換えａａｖ生成のための組成物及び方法
|
|
WO2024215655A1
(en)
|
2023-04-10 |
2024-10-17 |
Tenaya Therapeutics, Inc. |
Cardioprotective bag3 therapies
|
|
EP4695396A1
(en)
|
2023-04-10 |
2026-02-18 |
Tenaya Therapeutics, Inc. |
Guide rnas, vectors, and virions for targeting mutations in the pln gene
|
|
EP4694904A2
(en)
|
2023-04-13 |
2026-02-18 |
REGENXBIO Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2024229389A1
(en)
*
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
JP2026515970A
(ja)
*
|
2023-05-04 |
2026-05-19 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖカプシドバリアント及びその使用
|
|
EP4709866A2
(en)
|
2023-05-07 |
2026-03-18 |
REGENXBIO Inc. |
Compositions and methods for recombinant aav production
|
|
WO2024238859A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Vectorized c5 inhibitor agents and administration thereof
|
|
WO2024238853A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Adeno-associated viruses for ocular delivery of gene therapy
|
|
WO2024238867A1
(en)
|
2023-05-16 |
2024-11-21 |
Regenxbio Inc. |
Vectorized anti-complement antibodies and administration thereof
|
|
CN121219325A
(zh)
*
|
2023-05-23 |
2025-12-26 |
北京因诺惟康医药科技有限公司 |
一种腺相关病毒衣壳蛋白、包含其的腺相关病毒、载体及应用
|
|
WO2025008406A1
(en)
|
2023-07-04 |
2025-01-09 |
Institut National de la Santé et de la Recherche Médicale |
Antisense oligonucleotides and their use for the treatment of cancer
|
|
KR20260039752A
(ko)
|
2023-07-13 |
2026-03-20 |
크리야 테라퓨틱스, 인크. |
보체 경로 억제제 융합체 및 그의 사용 방법
|
|
CN117230117A
(zh)
*
|
2023-08-04 |
2023-12-15 |
中国科学院深圳先进技术研究院 |
重组腺相关病毒包装质粒、突变体及其制备方法和应用
|
|
TW202508610A
(zh)
|
2023-08-23 |
2025-03-01 |
大陸商上海瑞宏迪醫藥有限公司 |
醫藥組成物及其用途
|
|
KR20260082361A
(ko)
|
2023-08-31 |
2026-06-04 |
디노 테라퓨틱스, 인코포레이티드 |
캡시드 폴리펩타이드 및 이의 사용 방법
|
|
CN117143203B
(zh)
*
|
2023-09-06 |
2026-03-03 |
广州译码基因科技有限公司 |
可提高aav病毒全眼感染能力的衣壳蛋白突变体及其应用
|
|
WO2025075963A1
(en)
|
2023-10-02 |
2025-04-10 |
Regenxbio Inc. |
Methods and formulations for treating mucopolysaccharidosis ii-associated hearing loss with recombinant human iduronate-2-sulfatase
|
|
WO2025090962A1
(en)
|
2023-10-25 |
2025-05-01 |
Regenxbio Inc. |
Compositions and methods for recombinant aav production
|
|
CN117247434B
(zh)
*
|
2023-11-10 |
2024-02-02 |
上海朗昇生物科技有限公司 |
衣壳修饰型病毒载体及其制备和用途
|
|
WO2025106374A1
(en)
|
2023-11-13 |
2025-05-22 |
Juno Therapeutics, Inc. |
Aav production method
|
|
AU2024386366A1
(en)
|
2023-11-23 |
2026-06-04 |
Neuexcell Therapeutics (Suzhou) Co., Ltd. |
Gene therapy compositions and methods for treating glioma
|
|
WO2025113676A1
(en)
|
2023-11-29 |
2025-06-05 |
Neuexcell Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treating stroke in primates
|
|
WO2025129085A1
(en)
|
2023-12-15 |
2025-06-19 |
Port Therapeutics, Inc. |
Use of thermal bioswitches in aav-based gene therapy
|
|
CN119080889B
(zh)
*
|
2024-09-18 |
2025-06-24 |
广州译码基因科技有限公司 |
提高aav对眼组织感染能力的衣壳蛋白突变体及应用
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
WO2025217214A2
(en)
|
2024-04-08 |
2025-10-16 |
Regenxbio Inc. |
Recombinant adeno-associated viruses and uses thereof
|
|
WO2025217230A1
(en)
*
|
2024-04-08 |
2025-10-16 |
Regenxbio Inc. |
Vectorized anti-complement antibodies and complement agents and administration thereof
|
|
WO2025214408A1
(en)
|
2024-04-10 |
2025-10-16 |
Skyline Therapeutics (Shanghai) Co., Ltd. |
Optogenetic modulation for vision restoration
|
|
WO2025214404A1
(en)
|
2024-04-10 |
2025-10-16 |
Skyline Therapeutics (Shanghai) Co., Ltd. |
Optogenetic modulation for vision restoration
|
|
WO2025237990A1
(en)
|
2024-05-14 |
2025-11-20 |
Institut National de la Santé et de la Recherche Médicale |
Antisense oligonucleotides and their use for the treatment of pulmonary fibrosis
|
|
CN121046460A
(zh)
*
|
2024-05-31 |
2025-12-02 |
上海朗昇生物科技有限公司 |
用于治疗Prom1相关视网膜疾病的新型治疗药物
|
|
WO2026006341A1
(en)
|
2024-06-24 |
2026-01-02 |
Regenxbio Inc. |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
TW202607144A
(zh)
|
2024-07-16 |
2026-02-16 |
美商愛德維仁生物科技公司 |
使用編碼阿柏西普（ａｆｌｉｂｅｒｃｅｐｔ）之ａａｖ２變異體治療眼部新生血管性疾病的方法
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026080515A2
(en)
|
2024-10-08 |
2026-04-16 |
Regeneron Pharmaceuticals, Inc. |
Crispr sam biosensor cells and cell lines and methods of use thereof
|
|
CN118955654B
(zh)
*
|
2024-10-15 |
2025-05-16 |
朗信启昇(苏州)生物制药有限公司 |
具有变异衣壳的腺相关病毒病毒体及其用途
|
|
WO2026102076A1
(en)
|
2024-11-07 |
2026-05-15 |
Juno Therapeutics, Inc. |
Aav production method
|
|
WO2026114267A1
(en)
|
2024-11-29 |
2026-06-04 |
Neuexcell Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treating alzheimer's disease in primates
|
|
WO2026122963A1
(en)
|
2024-12-06 |
2026-06-11 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
EP4763209A1
(en)
|
2024-12-17 |
2026-06-24 |
Institut National de la Santé et de la Recherche Médicale |
Use of (alpha)s-setmar agonist for preventing or treating glioblastoma
|
|
WO2026137014A1
(en)
|
2024-12-20 |
2026-06-25 |
Samsung Bioepis Co., Ltd. |
Methods of purifying recombinant adeno-associated viruses
|
|
CN122255230A
(zh)
*
|
2026-05-12 |
2026-06-23 |
沈阳兴齐眼药股份有限公司 |
Aav衣壳蛋白变体及其应用
|